Online education and training provided through programs, modules, and presentations

The Latest

In this month’s “Virtual Lecture,” James Stubbs, M.D., will discuss the concept of remote damage control resuscitation (RDCR) and the use of new “old” blood components that could potentially increase effectiveness of RDCR.
By MML Education • November 14, 2017
In this month’s "Hot Topic," Bobbi Pritt, M.D., will discuss a powerful new technology called "multiplex molecular testing" that can assist in the diagnosis of gastrointestinal infections.
By Bobbi Pritt, M.D. • November 6, 2017
The purpose of this "Virtual Lecture" presentation by Karen Fritchie, M.D., is to demystify fatty tumors from their morphology to their molecular biology, while providing practical points that can be put into action immediately.
By MML Education • October 17, 2017
In this month’s "Hot Topic," Matt Binnicker, Ph.D., explains how syndromic testing can be used to diagnose viral and bacterial respiratory infections, the advantages of using this method, and when a syndromic respiratory panel should be ordered.
By Matthew Binnicker, Ph.D. • October 2, 2017
In this month’s "Hot Topic," D. Jane Hata, Ph.D., provides an overview of the epidemiology of Zika virus, as well as the possible clinical features of disease and the recommended laboratory tests to assist in the diagnosis of Zika virus infection.
By Jane Hata, Ph.D. • September 18, 2017
In this "Hot Topic," Nicole Hoppman, Ph.D., discusses mate-pair sequencing, which is the first clinically available test that can characterize almost any chromosomal rearrangement, helping to establish pathogenicity, and, in a neoplastic setting, assist in diagnosis, prognosis, and identification of optimal therapeutic options.
By Nicole Hoppman, Ph.D. • September 5, 2017
In this "Virtual Lecture" presentation Dr. David Ahlquist helps guide a new way of thinking about cancer screening using new molecular technology.
By MML Education • August 31, 2017
This month's "Hot Topic" will provide you with valuable information regarding the utility of the prostate specific antigen test, and how the calculation of a prostate health index, or phi, can help to stratify a patient’s risk for prostate cancer and reduce unnecessary biopsies.
By Alicia Algeciras-Schimnich, Ph.D. • August 14, 2017